An Open Label, Expanded Access Study of Melphalan Chemosaturation With the Delcath System in Patients With Ocular and Cutaneous Melanoma Metastatic to the Liver
Sponsor study identifier
expanded_access
N/A
1 country
6
Study Start
Not reported
Date not reportedPrimary Completion
Not reported
Date not reportedStudy Completion
Not reported
Date not reportedThe safety and efficacy of CS-PHP-melphalan has been evaluated in a phase 3 trial conducted in the same patient population as well as using the same melphalan dosing as proposed in this study. This expanded access protocol will provide an experimental alternative treatment option for both physicians and patients until the Delcath CS-PHP System receives marketing approval.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 13, 2012
Actual (reported)November 16, 2012
Actual (reported)Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
John Wayne Cancer Institute at Saint John's Health Center
Santa Monica, California, 90404, United States
Sky Ridge Medical Center
Englewood, Colorado, 80112, United States
H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
Tampa, Florida, 33612-9497, United States
University of Maryland Medical Center
Baltimore, Maryland, 21201, United States
Carol G. Simon Cancer Center at Morristown Memorial Hospital
Morristown, New Jersey, 07962-1956, United States
University of Pittsburg Cancer Institute
Pittsburgh, Pennsylvania, 15232, United States
Charles W Nutting, DO
Sky Ridge Medical Center
Jonathan Zager, MD
H. Lee Moffitt Cancer Center and Research Institue at University of Southern Florida
Mark Faries, MD
Saint John's Cancer Institute
James F Pingpank, MD
Univeristy of Pittsburg Cancer Center
First Submitted
November 13, 2012
First Posted
November 16, 2012
Last Updated
October 23, 2013
Record last verified: 2013-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Melphalan With BBBD in Treating Patients With Brain Malignancies
Contact the study team to confirm eligibility.
Eric D Whitman, MD
Carol G. Simon Cancer Center at Morristown Memorial Hospital
H. Richard Alexander, MD
University of Maryland, Baltimore